Wednesday, 4 November 2026
DRC Ebola cases surpass 10,000, First continuous ketone monitor authorised, Paediatric warning system expands
- 01
DRC Bundibugyo Ebola outbreak surpasses 10,000 confirmed cases
After the previously reported Bundibugyo Ebola case in Nigeria, confirmed cases in the Democratic Republic of the Congo outbreak have surpassed 10,000. Almost 5,000 people have died, the country’s health ministry announced on 30 October. The outbreak is driven by the rare Bundibugyo virus, for which no vaccine is currently approved, although a phase 2/3 clinical trial is under way. Recent fatalities included Marie-France Shogogo, a doctor working in northeastern DRC, according to the Africa Centres for Disease Control and Prevention.
via BMJ
- 02
FDA authorises first continuous ketone monitor for type 1 diabetes
The US Food and Drug Administration authorised the first wearable device that continuously monitors ketone levels in people with type 1 diabetes. The authorisation introduces continuous ketone monitoring for this population. The source gives limited detail about the device or the authorisation.
via JAMA
- 03
Paediatric deterioration warning system to expand across England’s emergency departments
A standardised early warning system for deteriorating children will be rolled out across England’s emergency departments this winter. The Paediatric Early Warning System requires staff to measure, record and assess vital signs, with higher scores prompting more urgent attention. NHS England said care can also be escalated when staff, parents or patients raise concerns, even if the clinical score is low. The system is already used across 90 paediatric inpatient wards, and NHS England said participating trusts have consistently lower cardiac arrest rates; age-appropriate charts reflect the differing clinical needs of babies, children and teenagers.
via BMJ
- 04
US study examines occupational patterns in heat-related deaths
A US nationwide surveillance study examined heat-related mortality across occupation and industry sectors from 2021 to 2023. It included people aged 16 to 64 years. The source gives limited detail and does not report results or identify sectors with higher mortality.
via JAMA
- 05
UK study to measure population exposure to PFAS and metals
UK health officials will launch a population study measuring exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS), lead and arsenic through blood and urine samples. The UK Health Security Agency expects initial findings in 2027 and will examine potential effects on human health. The agency said evidence on the health effects of PFAS remained limited, although the strongest available data indicated possible links with raised cholesterol concentrations and lower birth weight. PFAS comprise more than 10,000 human-made chemicals used since the 1950s in industrial processes and products including food packaging, non-stick cookware, clothing, cosmetics, firefighting foams, waterproofing and medicines.
via BMJ
- 06
Routine gastric residual volume checks in paediatric intensive care questioned
Routine gastric residual volume assessment in critically ill children should be deimplemented, according to correspondence in JAMA discussing the GASTRIC-PICU trial. The authors described the trial as addressing a long-standing paediatric intensive care practice supported by weak evidence. They said the case for ending routine assessment was likely to change bedside care. The correspondence raised two points intended to strengthen interpretation of the study, but the supplied source gives no details of these points or the trial results.
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.